[B! åŒ»ç™‚] poccopenã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

poccopen id:poccopen

åŒ»ç™‚ã«é–¢ã™ã‚‹poccopenã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (42)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

20-40ä»£ã€åƒãç››ã‚Šã®çš†ã•ã‚“ï¼ˆç‰¹ã«ç”·æ€§ï¼‰ã«çŸ¥ã£ã¦ã»ã—ã„ã€Œé¢¨ç–¹ã€ã®ã“ã¨ - kobeniã®æ—¥è¨˜
é¢¨ç–¹ãŒæ±äº¬ã‚’ä¸å¿ƒã«å¤§æµè¡Œä¸ã¨ã„ã†ã“ã¨ã§ã€ã“ã®ãƒ‹ãƒ¥ãƒ¼ã‚¹ã‚’ãšã£ã¨æ°—ã«ã—ã¦è¿½ã„ã‹ã‘ã¦ã„ã¾ã™ã€‚ãã‚Œã«ã¯ç†ç”±ãŒã‚ã£ã¦ã€ç§ã¯ä»Šã‹ã‚‰4å¹´å‰ã®å¦Šå¨ ä¸ã«ã€åˆæœŸã®è¡€æ¶²æ¤œæŸ»ã§ã€Œé¢¨ç–¹ã®æŠ—ä½“ãŒéžå¸¸ã«ä½Žã„ã€ã¨ãŠåŒ»è€…ã•ã‚“ã‹ã‚‰è¨€ã‚ã‚ŒãŸçµŒé¨“ãŒã‚ã‚‹ã‹ã‚‰ã§ã™ã€‚ã„ã¾ã€é¢¨ç–¹ã®æ„ŸæŸ“æºã¨ãªã£ã¦ã„ã‚‹ã®ã¯20-40ä»£ã®ç”·å¥³ã€ã‚€ã‹ã—äºˆé˜²æŽ¥ç¨®ã‚’ã—ã¦ã„ãªã„ä¸–ä»£ã ã¨è¨€ã‚ã‚Œã¦ã„ã¾ã™ã€‚ã§ã€ã‚ˆãè€ƒãˆãŸã‚‰ã€ã€Œã¯ã¦ãªã€ã£ã¦ã“ã®ä¸–ä»£ã®ç”·å¥³ã€ç‰¹ã«ç”·æ€§ãŒã‚ˆãèªã‚“ã§ã‚‹ã˜ã‚ƒãªã„ã§ã™ã‹ã€‚ç§ã¯ã©ã£ã¡ã‹ã¨ã„ã†ã¨ç”·æ€§ã€å°‘ã—ã§ã‚‚å¤šãã®ç”·æ€§ã«ã“ã®è©±ã‚’çŸ¥ã£ã¦ã»ã—ãã€ã¡ã‚‡ã£ã¨æ›¸ã„ã¦ã¿ã‚‹ã“ã¨ã«ã—ã¾ã—ãŸã€‚ æœ¬æ–‡ä¸ã®å¼•ç”¨ã¯ã€ã™ã¹ã¦NHKã®ã€Œã‚¹ãƒˆãƒƒãƒ—é¢¨ç–¹ã€ã‚µã‚¤ãƒˆã‹ã‚‰ã§ã™ã€‚ http://www3.nhk.or.jp/news/stopfushin/ ã€Œã“ã¨ã—ã«å…¥ã£ã¦å›½å†…ã®æ„ŸæŸ“è€…ã¯2000äººã‚’è¶…ãˆã€åŽ»å¹´åŒæ™‚æœŸã®20å€ä»¥ä¸Šã¨éŽåŽ»æœ€æ‚ªã®ãƒšãƒ¼ã‚¹ã§æ„ŸæŸ“ãŒåºƒãŒã£ã¦ã„ã¾ã™ã€‚ æ‚£è€…ã®8å‰²è¿‘ããŒç”·æ€§ã§ã€ãã®
poccopen 2013/05/08
å‡ºç”£

åŒ»ç™‚

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
A test for Parkinson's with a phone call
Go deeper into fascinating topics with original video series from TED
poccopen 2012/11/18
TED

å‹•ç”»

åŒ»ç™‚

æŠ€è¡“
ãƒªãƒ³ã‚¯
The promise of research with stem cells
poccopen 2012/11/12
TED

å‹•ç”»

ç”Ÿç‰©

ç§‘å¦

åŒ»ç™‚
ãƒªãƒ³ã‚¯
ä¸å¦ŠåŽŸå› ã€Œåµåã®è€åŒ–ã€ãŒç´„åŠæ•°ã€€NHKãƒ‹ãƒ¥ãƒ¼ã‚¹
å¤šãã®å¤«å©¦ãŒä¸å¦Šã«æ‚©ã‚€åŽŸå› ã‚„èƒŒæ™¯ã‚’æŽ¢ã‚‹ãŸã‚ã€ï¼®ï¼¨ï¼«ãŒå…¨å›½ã®å°‚é–€åŒ»ç™‚æ©Ÿé–¢ã«èª¿æŸ»ã‚’è¡Œã£ãŸã¨ã“ã‚ã€å¥³æ€§ãŒå¹´ã‚’é‡ãã‚‹ã¨ã¨ã‚‚ã«å¦Šå¨ ã—ã¥ã‚‰ããªã‚‹ã€ã€Œåµåã®è€åŒ–ã€ã«åŽŸå› ãŒã‚ã‚‹æ‚£è€…ã®å‰²åˆãŒåŠæ•°è¿‘ãã«ä¸Šã‚‹ã“ã¨ãŒã€åˆã‚ã¦æ˜Žã‚‰ã‹ã«ãªã‚Šã¾ã—ãŸã€‚ å°‚é–€å®¶ã¯ã€Œåµåã®è€åŒ–ãŒçŸ¥ã‚‰ã‚Œã¦ã„ãªã„ã“ã¨ãŒã€ä¸å¦Šã«æ‚©ã‚€å¤«å©¦ã®å¢—åŠ ã«æ‹è»Šã‚’ã‹ã‘ã¦ã„ã‚‹ã€ã¨æŒ‡æ‘˜ã—ã¦ã„ã¾ã™ã€‚ ä¸å¦Šã®æ¤œæŸ»ã‚„æ²»ç™‚ã‚’å—ã‘ãŸå¤«å©¦ã¯ï¼–çµ„ã«ï¼‘çµ„ã«ä¸Šã‚Šã€ã‚ˆã‚Šé«˜åº¦ãªä¸å¦Šæ²»ç™‚ã§ã‚ã‚‹ä½“å¤–å—ç²¾ã®ä»¶æ•°ã¯å¹´é–“ã§ï¼’ï¼‘ä¸‡ä»¶ã¨ã€ï¼•å¹´ã§å€å¢—ã—ã¦ã€ä¸–ç•Œæœ€å¤šã«ãªã‚Šã¾ã—ãŸã€‚ ï¼®ï¼¨ï¼«ã§ã¯ã€ãã®åŽŸå› ã‚„èƒŒæ™¯ã‚’æŽ¢ã‚‹ãŸã‚ã€å…ˆæœˆã‹ã‚‰ä»Šæœˆã«ã‹ã‘ã¦èª¿æŸ»ã‚’è¡Œã„ã€å…¨å›½ã®å°‚é–€åŒ»ç™‚æ©Ÿé–¢ã®åŠæ•°ã«å½“ãŸã‚‹ãŠã‚ˆãï¼“ï¼ï¼ã¨ã€ä¸å¦Šæ²»ç™‚ã‚’ã—ã¦ã„ã‚‹æ‚£è€…ãªã©ï¼˜ï¼ï¼ï¼äººä½™ã‚Šã‹ã‚‰å›žç”ã‚’å¾—ã¾ã—ãŸã€‚ ã“ã®ã†ã¡ã€åŒ»ç™‚æ©Ÿé–¢ã«å¯¾ã—ã¦ã€ä¸å¦Šã®åŽŸå› ã«ã¤ã„ã¦èžã„ãŸã¨ã“ã‚ã€å¥³æ€§ã§ã¯ã€ï¼“ï¼ä»£åŠã°ã‚’éŽãŽã‚‹ã¨åµåã®è³ªãŒä½Žä¸‹ã—ã¦å¦Šå¨ ã—ã¥ã‚‰ããªã‚‹ã€Œåµåã®è€åŒ–ã€ã«åŽŸå› ãŒã‚
poccopen 2012/06/24
åŠ é½¢ã«ã¨ã‚‚ãªã£ã¦æ¸›æ•°åˆ†è£‚ä¸ã«æŸ“è‰²ä½“ä¸åˆ†é›¢ã‚’ç”Ÿã˜ã‚‹åµåã®å‰²åˆãŒå¢—ãˆã‚‹ã“ã¨ãŒå ±å‘Šã•ã‚Œã¦ãŠã‚Šã¾ã™ã§ã™ã€‚ã‚³ãƒ’ãƒ¼ã‚·ãƒ³ and/or ã‚³ãƒ³ãƒ‡ãƒ³ã‚·ãƒ³ã®ç›´æŽ¥çš„é–¢ä¸Žã‚’ç¤ºã™ã‚»ãƒŸãƒŠãƒ¼ã‚’èžã„ãŸè¨˜æ†¶ãŒã‚ã‚Šã¾ã™ãŒã€ã†ã‚è¦šãˆã§ãƒ»ãƒ»ãƒ»ã€‚

åŒ»ç™‚

ç¤¾ä¼š

ç”Ÿç‰©

ç§‘å¦
ãƒªãƒ³ã‚¯
äºˆé˜²æŽ¥ç¨®æ³•æ”¹æ£ã€€æ ¼å¥½ã¤ã‘ã¦ã‚‚åŠã³è…°ã€€é€ã‘ã‚‹åŽšåŠ´çœã®å§¿å‹¢ï½œãƒãƒã‚¹ãƒ»ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«
ï¼“æœˆ20æ—¥ç™ºè¡Œã®ï¼”æœˆå·ã«æŽ²è¼‰ã®è¨˜äº‹ã§ã™ãŒã€æ–‡ä¸ã«å‡ºã¦ãã‚‹ã€Žèª¤ç”å¼é¨’å‹•ã€ãŒæœ¬å½“ã«ã€Žèª¤ç”å¼ã€ã¨ã—ã¦å‡¦ç†ã•ã‚Œã¦ã—ã¾ã£ãŸã‚ˆã†ãªã®ã§ã€æš—æ¾¹ãŸã‚‹æ°—æŒã¡ã§å…ˆè¡Œå…¬é–‹ã—ã¾ã™ã€‚ å°‚é–€å®¶ã®æ„è¦‹ã¨åŽšåŠ´çœæ¡ˆã‚’ã‚ãƒ¼ã‚°ãƒ©ãƒ•Â®æ¯”è¼ƒ äºˆé˜²æŽ¥ç¨®æ³•ãŒã€å°‚é–€å®¶ãŸã¡ã®ï¼’å¹´ä»¥ä¸Šã®è°è«–ã‚’çµŒã¦ã€æ”¹æ£ã•ã‚Œã‚ˆã†ã¨ã—ã¦ã„ã¾ã™ã€‚åŽšç”ŸåŠ´åƒçœã®æ³•æ”¹æ£æ¡ˆãŒã€å°‚é–€å®¶ãŸã¡ã®è°è«–ã‚’æ£ã—ãåæ˜ ã—ã¦ã„ã‚‹ã‹ã€å¤§æ¾¤å¹¸ç”Ÿãƒ»æ±äº¬å¤§å¦å·¥å¦ç³»å¤§å¦é™¢æ•™æŽˆã«ã‚ãƒ¼ã‚°ãƒ©ãƒ•Â®è§£æžï¼ˆï¼Šï¼‰ã—ã¦ã‚‚ã‚‰ã„ã¾ã—ãŸã€‚æ¥µã‚ã¦èˆˆå‘³æ·±ã„å·®ç•°ãŒè¦‹ã¤ã‹ã‚Šã¾ã—ãŸã€‚ ã‚ãƒ¼ã‚°ãƒ©ãƒ•Â®è§£æžã€€æ–‡ç« ã‚’æ§‹æˆã™ã‚‹å˜èªžã®ç™»å ´é »åº¦ã€äº’ã„ã®ç¹‹ãŒã‚Šã®å¼·ã•ã‚„æ•°ã‚’è¨ˆç®—ã—ã€é‡è¦ãªå½¹å‰²ã‚’æžœãŸã—ã¦ã„ã‚‹å˜èªžã‚’åˆ†é¡žãƒ»æŠ½å‡ºã—ã€çµæžœã‚’ãƒãƒƒãƒˆãƒ¯ãƒ¼ã‚¯å›³ã¨ã—ã¦è¦–è¦šåŒ–ã™ã‚‹ã“ã¨ã§ã€æ–‡ç« ã®åŠ›ç‚¹ãŒã©ã“ã«ç½®ã‹ã‚Œã¦ã„ã‚‹ã‹æµ®ã‹ã³ä¸ŠãŒã‚‰ã›ã‚‹ã‚‚ã®ã§ã™ã€‚é»’ç‚¹ã§ç¤ºã•ã‚Œã‚‹ã®ã¯æ–‡ä¸ã«ä½¿ã‚ã‚Œã‚‹é »åº¦ã®é«˜ã„å˜èªžã§ã™ã€‚èµ¤ç‚¹ã§ç¤ºã•ã‚Œã‚‹ã®ã¯ã€å‡ºç¾é »åº¦ã¯ä½Žã„ã‚‚ã®ã®é‡è¦ãªåƒãã‚’ã—ã¦ã„ã‚‹å˜èªžã§ã™ã€‚
poccopen 2012/03/15
åŒ»ç™‚

è¡Œæ”¿

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
ã‚¼ãƒ³ãƒ¡ãƒ«ãƒ¯ã‚¤ã‚¹ã®ç‰©èªž - ã¨ãƒ©ãã“æ—¥èªŒ
ã‚‚ã—ã‚‚ç”£ç§‘åŒ»å¸«ãŒè‡ªã‚‰ã®èª¤ã£ãŸè§£é‡ˆã‚„æ‰‹æŠ€ãŒåŽŸå› ã§ã€æœ¬æ¥å®ˆã‚‹ã¹ãæ¯åã®å¥åº·ã‚’æãªã£ã¦ããŸäº‹ã‚’æŒ‡æ‘˜ã•ã‚ŒãŸã¨ã™ã‚Œã°ã€ãã‚Œã‚’ç´ ç›´ã«å—ã‘å…¥ã‚Œã‚‹äº‹ãŒå‡ºæ¥ã‚‹ã®ã§ã—ã‚‡ã†ã‹ã€‚ ãã‚ŒãŒã€äººã®æ»ã¨ç›´çµã™ã‚‹ã‚ˆã†ãªäº‹ã§ã‚ã‚Œã°ã€èªã‚ã‚‹äº‹ã¯ç°¡å˜ãªäº‹ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ã©ã‚‰ãã“ã§ã‚ã‚Œã°ã€çœŸã£æ£é¢ã‹ã‚‰å—ã‘æ¢ã‚ã‚‹äº‹ãŒã§ããšã€ç¾å®Ÿé€ƒé¿ã‚„ç„¡ç†ç‹ãªåé§ã‚’è¡Œã£ã¦ã—ã¾ã†ã‹ã‚‚çŸ¥ã‚Œã¾ã›ã‚“ã€‚å¤šãã®äººã«ã¨ã£ã¦ã€å–ã‚Šè¿”ã—ã®ã¤ã‹ãªã„ã‚ˆã†ãªéŽã¡ã‚’å—ã‘æ¢ã‚ã‚‹ã“ã¨ã¯å¤§å¤‰ã«å›°é›£ãªäº‹ã§ã‚ã‚‹ã¨æ€ã„ã¾ã™ã€‚ã“ã‚Œã¯ä»£æ›¿åŒ»ç™‚ã‚„æ ¹æ‹ ã®ãªã„å¥åº·æ³•ã«åµŒã£ã¦ã—ã¾ã£ãŸäººãŒå¾Œæˆ»ã‚Šã§ããªã„ç†ç”±ã®ä¸€ã¤ã§ã‚ã‚‹ã¨æ€ã£ã¦ãŠã‚Šã¾ã™ã€‚ãƒãƒ³ã‚¬ãƒªãƒ¼å‡ºèº«ã®åŒ»å¸«ã‚¼ãƒ³ãƒ¡ãƒ«ãƒ¯ã‚¤ã‚¹ã¯ãã‚“ãªç½ªã®æ„è˜ã¨é—˜ã„ã€éŽã¡ã‚’å„Ÿã†ãŸã‚ã«ãã®äººç”Ÿã‚’æ§ã’ã¾ã—ãŸã€‚ ã“ã®ç‰©èªžã‚’æ›¸ãã«ã‚ãŸã£ã¦ã¯ã€å—å’Œå˜‰ç”·è‘— åŒ»å¸«ã‚¼ãƒ³ãƒ¡ãƒ«ãƒ¯ã‚¤ã‚¹ã®æ‚²åŠ‡ã€€è¬›è«‡ç¤¾åˆŠï¼ˆçµ¶ç‰ˆï¼‰ã‚’å¤§ããå‚è€ƒã«ã•ã›ã¦ã„ãŸã ã„ã¦ãŠã‚Šã¾ã™ã€‚ãã®ä»–ã€ãƒˆãƒ¼ãƒ«ãƒ¯ã‚¤ãƒ‰è‘— å¡©æœˆæ£é›„è¨³ã€€å¤–ç§‘ã®å¤œæ˜Žã‘
poccopen 2011/08/13
äººé¡žãŒã€Œç´°èŒãŒæ„ŸæŸ“ç—‡ã‚’å¼•ãèµ·ã“ã™ã€ã£ã¦ã„ã†èªè˜ã‚’å¾—ã¦ã‹ã‚‰ã€ã¾ã 150å¹´ã»ã©ãªã‚“ã§ã™ãã‡ã€‚ï¼ãŠãã‚‰ãã‚¼ãƒ³ãƒ¡ãƒ«ãƒ¯ã‚¤ã‚¹ã¯ã€è‡ªåˆ†ã®æ¶ˆæ¯’æ³•ãŒå®Ÿéš›ã¯ä½•ã‚’ã€Œæ¶ˆæ¯’ã€ã—ã¦ã„ãŸã®ã‹çŸ¥ã‚‰ãªã„ã¾ã¾äº¡ããªã£ã¡ã‚ƒã£ãŸã‚“ã§ã™ã‚ˆãã‡ã€‚

åŒ»ç™‚

äººç‰©

æ´å²
ãƒªãƒ³ã‚¯
å¸Œå°‘ãƒ»é›£æ²»æ€§ç–¾æ‚£ã¨ãƒžã‚¤ã‚¯ãƒãƒ‰ãƒãƒ¼ã‚·ãƒ§ãƒ³ - è‰ã‚³ãƒãƒ³
åŒ»ç™‚å¸Œå°‘ãƒ»é›£æ²»æ€§ç–¾æ‚£ã€‚rare diseaseã¨ã‹orphan diseaseã¨ã‹è¨€ã„ã¾ã™ã€‚rareã¯ãƒ¬ã‚¢ã§orphanã¯å¤ç«‹ç„¡æ´ã®æ„å‘³ã§ã™ã€‚diseaseã‚’ä»˜ã‘ã‚‹ã¨ã€è¾žæ›¸çš„ã«ã¯å¥‡ç—…ã¨è¨³ãŒã¤ã„ã¦ã„ã‚‹ã®ã ã‘ã©ã€æœ€è¿‘ã¯å¸Œå°‘ãƒ»é›£æ²»æ€§ç–¾æ‚£ã¨å‘¼ã¶ã¿ãŸã„ã§ã™ãã€‚neglected diseaseã€Œé¡§ã¿ã‚‰ã‚Œãªã„ç—…æ°—ã€ã¨ã„ã†ã®ã‚‚ã‚ã‚‹ã®ã ã‘ã‚Œã©ã€åŒã˜ã‚‚ã®ã‚’æŒ‡ã™ã¨æ€ã„ã¾ã™ã€‚ http://en.wikipedia.org/wiki/Rare_diseaseã‚„wikipedia:å¸Œå°‘ç–¾ç—…ç”¨åŒ»è–¬å“ã‚’å‚ç…§ã€‚ã¾ãšã€rareã£ã¦ã©ã®ãã‚‰ã„ã®ã“ã¨ã„ã†ã®ã‹ã€‚äº‹ã®æ€§è³ªä¸Šã€ã‚ã‚“ã¾ã‚Šæ˜Žç¢ºã«ç·šå¼•ãã‚’ã—ã¦ã„ãªã„ã‚ˆã†ã§ã™ãŒã€çµ±è¨ˆã‚„æ”¿ç–ã§ã¯ä½•ã‚‰ã‹ã®åŸºæº–ãŒå¿…è¦ã§ã™ã€‚ãã†ã„ã†ã‚ã‘ã§ã‚¢ãƒ¡ãƒªã‚«ã§ã¯å¯¾è±¡æ‚£è€…20ä¸‡äººä»¥ä¸‹ã€æ—¥æœ¬ã§ã¯å¯¾è±¡æ‚£è€…5ä¸‡äººæœªæº€ã‚’å¸Œå°‘ç–¾æ‚£ã¨ã—ã¦ã€ãã®ãŸã‚ã®åŒ»è–¬å“ã€ã‚ªãƒ¼ãƒ•ã‚¡ãƒ³ãƒ‰ãƒ©ãƒƒã‚°ã«æ”¯æ´ã‚’ã—ã¦ã„ã‚‹ã‚ˆã†ã§ã™ã€‚ä¸€èˆ¬çš„ã«ã¯åƒäººã€œæ•°ä¸‡äºº
poccopen 2011/07/13
ã‚ªãƒ³ãƒ©ã‚¤ãƒ³èªžæºè¾žå…¸ http://www.etymonline.com ã«ã‚ˆã‚‹ã¨ã€"donor"ã¨"donation"ã¯åŒã˜ãã‚‰ã„å¤ã„ï¼ˆ15ä¸–ç´€ï¼‰å˜èªžã¿ãŸã„ã§ã™ãŒã€"donate"ã¯å¾Œã«ãªã£ã¦"donation"ã‹ã‚‰é€†æˆã•ã‚ŒãŸã‚ˆã†ã§ã™ã‚ˆï¼ˆ19ä¸–ç´€å‰åŠï¼‰ã€‚

ç¤¾ä¼š

åŒ»ç™‚

ç§‘å¦

ã¾ã£ãŸãã‚‚ã£ã¦

æœ¬é¡Œã˜ã‚ƒãªã„ã§ã™ãŒ

ç´°ã‹ã™ãŽã‚‹ã¤ã£ã“ã¿â†’
ãƒªãƒ³ã‚¯
æ¬¡ä¸–ä»£ã‚·ãƒ¼ã‚±ãƒ³ã‚µãƒ¼ã‚’ä½¿ã£ãŸè¨ºæ– - è‰ã‚³ãƒãƒ³
ç§‘å¦, ã‚²ãƒŽãƒ ã€Œãƒ†ãƒ¼ãƒ©ãƒ¼ãƒ¡ã‚¤ãƒ‰åŒ»ç™‚ã£ã¦å‰ã€…ã‹ã‚‰è¨€ã£ã¦ã‚‹ã‘ã©ã€ã¡ã£ã¨ã‚‚å®Ÿç”¨åŒ–ã•ã‚Œãªã„ãã€ã¨æ¯ã«ãã‹ã‚ŒãŸã®ãŒ5å¹´ãã‚‰ã„å‰ã€‚æ‚£è€…ã®å…¨ã‚²ãƒŽãƒ ã‚’èªã‚“ã§*1è¨ºæ–ã«å½¹ç«‹ã¦ãŸã‚‰ã„ã„ãã¨ã„ã†è©±ã ã‘ã©ã€ãªã‹ãªã‹ãã®æœªæ¥ã¯ã‚„ã£ã¦ã“ãªã„ã€‚ Scienceã®ä»²é–“ã®Science Translational Medicineè«–æ–‡ã€‚ Whole-Genome Sequencing for Optimized Patient Management Deep Sequencing of Patient Genomes for Disease Diagnosis: When Will It Become Routine? ç´¹ä»‹è¨˜äº‹ã¯ã“ã‚Œã€‚ Genome study solves twinsâ€™ mystery condition : Nature News èªã‚“ã§ã¦20æ™‚ã‹21æ™‚ã®ãƒ†ãƒ¬ãƒ“ç•ªçµ„ã§å†ç¾VTRä½œã‚‰ã‚Œã¦ãã†ã¨æ€ã£ãŸã€‚
poccopen 2011/06/24
å€‹äººã‚²ãƒŽãƒ ã£ã¦ã€ä¸€å›žèªã‚“ã˜ã‚ƒãˆã°åŸºæœ¬çš„ã«ã¯ä¸€ç”ŸåŒã˜ãƒ‡ãƒ¼ã‚¿ã‚’ä½¿ã„ç¶šã‘ã‚‰ã‚Œã‚‹ã£ã¦è€ƒãˆã‚‹ã¨ã€ãªã«ã‚„ã‚‰ãŠå¾—æ„ŸãŒã‚ã‚‹ã‚ˆã†ãªæ°—ã‚‚ã—ã¾ã™ã€‚

ç”Ÿç‰©

ç§‘å¦

åŒ»ç™‚

è‹¥å¹²

æœ¬é¡Œã˜ã‚ƒãªã„ã§ã™ãŒâ†’
ãƒªãƒ³ã‚¯
BK8 SBOBET à¸—à¸²à¸‡à¹€à¸‚à¹‰à¸²à¹€à¸§à¹‡à¸šà¹à¸—à¸‡à¸šà¸à¸¥ à¹€à¸§à¹‡à¸šà¸«à¸§à¸¢ à¸žà¸™à¸±à¸™à¸à¸à¸™à¹„à¸¥à¸™à¹Œà¸—à¸µà¹ˆà¸”à¸µà¹ˆà¸—à¸µà¹ˆà¸ªà¸¸à¸”
BK8 à¹€à¸§à¹‡à¸šà¸•à¸£à¸‡ à¸à¸±à¸™à¸”à¸±à¸š 1à¸–à¹‰à¸²à¸ˆà¸°à¹ƒà¸«à¹‰à¸žà¸¹à¸”à¸–à¸¶à¸‡ bk8 à¹€à¸§à¹‡à¸šà¸•à¸£à¸‡à¸—à¸µà¹ˆà¸žà¸£à¹‰à¸à¸¡à¸•à¸à¸šà¹‚à¸ˆà¸—à¸¢à¹Œà¸„à¸§à¸²à¸¡à¸•à¹‰à¸à¸‡à¸à¸²à¸£à¸‚à¸à¸‡à¸„à¸¸à¸“ à¸¡à¸²à¸”à¹‰à¸§à¸¢à¸à¸²à¸£à¸šà¸£à¸´à¸à¸²à¸£à¹€à¸”à¹ˆà¸™à¹ƒà¸™à¸”à¹‰à¸²à¸™à¸«à¸§à¸¢à¸à¸à¸™à¹„à¸¥à¸™à¹Œà¸—à¸µà¹ˆà¸„à¸£à¸à¸šà¸„à¸¥à¸¸à¸¡à¸„à¸£à¸šà¸ˆà¸šà¸—à¸¸à¸à¸„à¸§à¸²à¸¡à¸•à¹‰à¸à¸‡à¸à¸²à¸£à¸—à¸µà¹ˆà¸«à¸¥à¸²à¸à¸«à¸¥à¸²à¸¢ à¸«à¸™à¹‰à¸²à¹€à¸‚à¹‰à¸²à¹€à¸¥à¹ˆà¸™à¸—à¸µà¹ˆà¸ªà¸¸à¸”à¹ƒà¸™à¹€à¸§à¸¥à¸²à¸™à¸µà¹‰ à¹€à¸£à¸²à¸žà¸£à¹‰à¸à¸¡à¸¡à¸à¸šà¹‚à¸à¸à¸²à¸ªà¹ƒà¸™à¸à¸²à¸£à¸—à¸³à¸à¸³à¹„à¸£à¸ˆà¸²à¸à¸à¸²à¸£à¹€à¸‚à¹‰à¸²à¹€à¸¥à¹ˆà¸™à¹ƒà¸«à¹‰à¸à¸±à¸šà¸„à¸¸à¸“à¹„à¸”à¹‰à¸à¸¢à¹ˆà¸²à¸‡à¸‡à¹ˆà¸²à¸¢ à¹€à¸žà¸£à¸²à¸°à¸—à¸µà¹ˆ bk8 à¹€à¸§à¹‡à¸šà¸•à¸£à¸‡ à¸™à¸±à¸à¹€à¸¥à¹ˆà¸™à¸ˆà¸°à¹„à¸”à¹‰à¸žà¸šà¸à¸±à¸šà¸«à¸§à¸¢à¸—à¸µà¹ˆà¸«à¸¥à¸²à¸à¸«à¸¥à¸²à¸¢ à¹„à¸¡à¹ˆà¸§à¹ˆà¸²à¸ˆà¸°à¹€à¸›à¹‡à¸™à¸«à¸§à¸¢à¸£à¸±à¸à¸šà¸²à¸¥ à¸«à¸§à¸¢à¸¥à¸²à¸§ à¸«à¸§à¸¢à¸®à¸²à¸™à¸à¸¢ à¸«à¸£à¸·à¸à¸«à¸§à¸¢à¸à¸·à¹ˆà¸™à¹† à¸à¸µà¸à¸¡à¸²à¸à¸¡à¸²à¸¢ à¹‚à¸”à¸¢à¸„à¸±à¸”à¸ªà¸£à¸£à¹à¸•à¹ˆà¸«à¸§à¸¢à¸„à¸¸à¸“à¸ à¸²à¸ž à¹€à¸‚à¹‰à¸²à¹€à¸¥à¹ˆà¸™à¸‡à¸²à¸¢à¹‚à¸”à¸¢à¹„à¸¡
poccopen 2011/03/27
ç½å®³å¯¾å¿œ

åŒ»ç™‚

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
ãƒ¨ã‚¦ç´ ã‚’å«ã‚€æ¶ˆæ¯’æ¶²ãªã©ã‚’é£²ã‚“ã§ã¯ã„ã‘ã¾ã›ã‚“ ï½œå ±é“ç™ºè¡¨è³‡æ–™ï½œåŽšç”ŸåŠ´åƒçœ
æ”¾å°„ç·šè¢«æ›ã®äºˆé˜²ã‚„æ²»ç™‚ã®ãŸã‚ã«ã€ãƒ¨ã‚¦ç´ ã‚’å«ã‚€æ¶ˆæ¯’å‰¤ã‚’é£²ã‚“ã§ã¯ã„ã‘ã¾ã›ã‚“ã€‚ã‚¤ãƒ³ã‚¿ãƒ¼ãƒãƒƒãƒˆç‰ã«æµã‚Œã¦ã„ã‚‹æ ¹æ‹ ã®ãªã„æƒ…å ±ã«æ³¨æ„ã—ã¦ãã ã•ã„ã€‚è©³ã—ãã¯æ”¾å°„ç·šåŒ»å¦ç·åˆç ”ç©¶æ‰€ï¼¨ï¼°ã‚’ã”è¦§ãã ã•ã„ã€‚ æ”¾å°„ç·šåŒ»å¦ç·åˆç ”ç©¶æ‰€ï¼¨ï¼°ãƒ›ãƒ¼ãƒ ãƒšãƒ¼ã‚¸ã¯ã“ã¡ã‚‰
poccopen 2011/03/15
åŒ»ç™‚

ç½å®³å¯¾å¿œ
ãƒªãƒ³ã‚¯
å¹¼å…ã®ä¸æ…®ã®äº‹æ•…ã‚’èª¿ã¹ã¦ã¿ã‚‹ - æ–°å°å…ç§‘åŒ»ã®ã¤ã¶ã‚„ã
â– æœ€è¿‘ã®ãƒ‡ãƒ¼ã‚¿ å¹¼å…ã¨ã¯å®šç¾©ä¸Šã€1ã€œ4æ³ã®åã©ã‚‚ã‚’æŒ‡ã—ã¾ã™ã€‚å¹¼å…ã®äº‹ã‚’è€ƒãˆã‚‹å‰ã«ã€ä¸–ã®ä¸ã«ã©ã‚Œã ã‘ã®æ•°ã®ä¸æ…®ã®äº‹æ•…ã«ã‚ˆã‚‹æ»äº¡ãŒèµ·ã“ã£ã¦ã„ã‚‹ã‹ã‚‰äººå£å‹•æ…‹çµ±è¨ˆã‹ã‚‰ãƒ”ãƒƒã‚¯ã‚¢ãƒƒãƒ—ã—ã¦è¦‹ã¾ã™ã€‚ å¹´ 1997 ï½¥ï½¥ï½¥ 2005 2006 2007 2008 2009 0æ³ 278 ï½¥ï½¥ï½¥ 174 149 127 144 124 1ã€œ4æ³ 422 ï½¥ï½¥ï½¥ 236 207 177 163 148 5ã€œ9æ³ 314 ï½¥ï½¥ï½¥ 230 169 150 128 138 10ã€œ14æ³ 185 ï½¥ï½¥ï½¥ 150 106 124 114 92 15ã€œ29æ³ 4223 ï½¥ï½¥ï½¥ 2249 2011 1796 1578 1532 30ã€œ44æ³ 2763 ï½¥ï½¥ï½¥ 2529 2322 2163 2104 1997 45ã€œ64æ³ 9104 ï½¥ï½¥ï½¥ 7571 6940 6392 6217 5952 65ã€œ79æ³ 11019 ï½¥ï½¥ï½¥ 1
poccopen 2011/03/11
sleepycottonæ§˜ multiplex00æ§˜ hayami_sæ§˜ å…ˆå¤©çš„ç•°å¸¸ã«ã‚ˆã‚‹æ»äº¡ã®æ¯”çŽ‡ãŒæ•°å—ä¸Šå¢—ãˆã¦ã‚‹ã®ã¯ã€æ»äº¡ç·æ•°ãŒæ¸›ã£ã¦ãã¦ã‚‹ãŸã‚ã§ã™ã€‚å¹¼å…äººå£ã‚ãŸã‚Šã®å…ˆå¤©ç•°å¸¸ã«ã‚ˆã‚‹æ»äº¡æ•°ã¯å¢—åŠ å‚¾å‘ã¨ã¯è¨€ãˆãªã„æ°—ãŒã—ã¾ã™ã§ã™ã€‚â†’http://is.gd/jDeYH7

åŒ»ç™‚

çµ±è¨ˆ
ãƒªãƒ³ã‚¯
ãŒã‚“æ»äº¡ãƒªã‚¹ã‚¯ã¨ã‚¢ã‚¹ãƒ”ãƒªãƒ³ - è‰ã‚³ãƒãƒ³
åŒ»ç™‚è¦‹ã‹ã‘ãŸã®ãŒAFPã€GIGAZINEã€GIZMODOãªã®ã§çœ‰ã«å”¾ã¤ã‘ã¦ãŸã‘ã©ã€Lancetè«–æ–‡ã ã—ã€æ¡ˆå¤–ã‚¢ãƒªãªã®ã‹ãªã¨ã¾ãŸNHSæ§˜ã«ãŠä¼ºã„ã‚’ç«‹ã¦ã¦ã¿ãŸ*1ã€‚Aspirin and cancer risk - Health News - NHS Choices è«–æ–‡Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials : The Lancet NHSè¨˜äº‹ã®æ–‡æœ«è¦‹ã¦ã¿ã‚‹ã¨åˆ†ã‹ã‚‹ã‘ã©ã€ã‚„ã¯ã‚Šã‚‚ã®ã™ã”ã„ãŸãã•ã‚“ã®ãƒ‹ãƒ¥ãƒ¼ã‚¹ã‚µã‚¤ãƒˆã§ç´¹ä»‹ã•ã‚ŒãŸä»•äº‹ã®ã‚ˆã†ã§ã™ã€‚ã„ã¤ã‚‚ã“ã“ã¯2,3ãã‚‰ã„ã—ã‹ãªã„ã€‚ ã‚¢ã‚¹ãƒ”ãƒªãƒ³ã£ã¦ã€Œãƒ¯ãƒ³ãƒ€ãƒ¼ãƒ‰ãƒ©ãƒƒã‚°ã€ã£ã¦å‘¼ã°ã‚Œã¦ã‚“ã ã€‚è§£ç†±éŽ®ç—›ä½œç”¨ã¨ã¯åˆ¥ã«ã€ä½Žå®¹é‡ã§æŠ—è¡€æ “è–¬ã¨ã—ã¦ã®ä½¿ç”¨ãŒã‚ã‚‹ã¿ãŸã„
poccopen 2010/12/10
ç ”ç©¶ã®æ„ç¾©ã‚’ç†è§£ãƒ»è©•ä¾¡ã—ã¤ã¤ã‚‚ã€ã€Œãƒ¡ã‚«ãƒ‹ã‚ºãƒ çŸ¥ã‚ŠãŸã„ç—‡ã€é‡ç¯¤æ‚£è€…ã®åƒ•ã¯ã€è‹¥å¹²ã‚‚ã‚„ã‚‚ã‚„ã—ãŸã‚Šã—ã¾ã™ã€‚èª°ã‹å¤§è…¸ãŒã‚“ç”±æ¥ã®ç´°èƒžæ ªã‚’ä½Žæ¿ƒåº¦ã‚¢ã‚¹ãƒ”ãƒªãƒ³åŸ¹åœ°ã§é£¼ã£ã¦ã¿ãŸã‚Šã—ã¦ã¾ã›ã‚“ã§ã—ã‚‡ã†ã‹ãƒ»ãƒ»ãƒ»ã€‚(â†å®‰ç›´)

åŒ»ç™‚

ç§‘å¦
ãƒªãƒ³ã‚¯
asahi.comï¼ˆæœæ—¥æ–°èžç¤¾ï¼‰ï¼šåµåãƒ“ã‚¸ãƒã‚¹ã€ç±³ã§æµ¸é€ã€€ç‰¹å®šã®æä¾›è€…ã«é«˜é¡è¬ç¤¼ã‚‚ - ã‚µã‚¤ã‚¨ãƒ³ã‚¹
ç±³ã‚³ãƒãƒ³ãƒ“ã‚¢å¤§æ§‹å†…ã§ã€å¥³åå¦ç”Ÿã«åµåæä¾›ã‚’å‘¼ã³ã‹ã‘ã‚‹ãƒã‚¹ã‚¿ãƒ¼ã€‚è¬ç¤¼ã¯ï¼˜åƒãƒ‰ãƒ«ï¼ˆç´„ï¼–ï¼–ä¸‡å††ï¼‰ã ï¼ï¼‘ï¼æœˆã€ãƒ‹ãƒ¥ãƒ¼ãƒ¨ãƒ¼ã‚¯ã€å‹ç”°å†™ã™ã€€ã€€ ã€€ã€Œåã©ã‚‚ãŒã»ã—ã„ã€ã¨ã„ã†å¤«å©¦ã®æ€ã„ã‚’ä»–äººã‹ã‚‰ã®åµåæä¾›ã§ã‹ãªãˆã‚‹ã€‚æ—¥æœ¬ã§ã¯å®¶æ—é–¢ä¿‚ãŒè¤‡é›‘ã«ãªã‚‹ãªã©ã®æ‡¸å¿µã‹ã‚‰ã»ã¨ã‚“ã©å–ã‚Šçµ„ã¾ã‚Œã¦ã„ãªã„ãŒã€ç±³å›½ã§ã¯ä¿é™ºã‚‚ããä¸€èˆ¬çš„ãªä¸å¦Šæ²»ç™‚ã¨ã—ã¦å®šç€ã—ã¦ã„ã‚‹ã€‚æä¾›è€…ã¸ã®è¬ç¤¼ãŒï¼“ï¼ï¼ä¸‡å††è¿‘ãã«é”ã™ã‚‹ã“ã¨ã‚‚ã‚ã‚‹ã€‚æ—¥æœ¬ã‹ã‚‰ã‚‚å¤šãã®äººãŒå‘ã‹ã†ã€ãã‚“ãªã€Œåµåãƒ“ã‚¸ãƒã‚¹ã€ã®ç¾å ´ã‚’è¦‹ãŸã€‚ ã€€ã€Œä»–ã®å¥³æ€§ãŒå¦Šå¨ ã§ãã‚‹ã‚ˆã†åŠ©ã‘ã¦ã‚ã’ã¦ãã ã•ã„ã€ ã€€ãƒ‹ãƒ¥ãƒ¼ãƒ¨ãƒ¼ã‚¯ã«ã‚ã‚‹åé–€å¤§å¦ã€ã‚³ãƒãƒ³ãƒ“ã‚¢å¤§ã®ã‚ãƒ£ãƒ³ãƒ‘ã‚¹ã«ã¯ã€ã“ã‚“ãªãƒã‚¹ã‚¿ãƒ¼ãŒå¼µã‚‰ã‚Œã¦ã„ã‚‹ã€‚åŒå¤§å¦ç”£ç§‘å©¦äººç§‘å¦æ•™å®¤ãŒã€å¦ç”Ÿã«åµåã®æä¾›ã‚’å‘¼ã³ã‹ã‘ã‚‹ã‚‚ã®ã ã€‚ ã€€æä¾›ã§ãã‚‹ã®ã¯ï¼’ï¼‘ã€œï¼“ï¼’æ³ã§è¬ç¤¼ã¯ï¼˜åƒãƒ‰ãƒ«ï¼ˆç´„ï¼–ï¼–ä¸‡å††ï¼‰ã€‚ç±³ç”Ÿæ®–åŒ»å¦ä¼šã®å€«ç†å§”å“¡ä¼šã¯ï¼’ï¼ï¼ï¼—å¹´ã€ã€Œï¼•åƒãƒ‰ãƒ«ã‚’è¶…ãˆã‚‹è¬ç¤¼ã¯æ£å½“åŒ–ã™ã‚‹å¿…è¦ãŒã‚ã‚Šã€ï¼‘ä¸‡ãƒ‰ãƒ«ã‚’
poccopen 2010/12/06
åŒ»ç™‚

ç¤¾ä¼š
ãƒªãƒ³ã‚¯
åˆ†åæ¨™çš„æ²»ç™‚ - Wikipedia
ã“ã®è¨˜äº‹ã¯éŽåº¦ã«ä¸€æ¬¡è³‡æ–™ã«åŸºã¥ã„ã¦ã„ã¾ã™ã€‚ã‚ã‚‹ã„ã¯æ¤œè¨¼å¯èƒ½æ€§ã®ãŸã‚ã«ã€åŒ»å¦ã«é–¢ã™ã‚‹ã€ã‚ˆã‚Šä¿¡é ¼ã§ãã‚‹æƒ…å ±æºã‚’å¿…è¦ã¨ã—ã¦ã„ã¾ã™ã€‚ å¯èƒ½ãªã‚‰å†…å®¹ã‚’è¦‹ç›´ã—é©åˆ‡ãªå‡ºå…¸ã‚’è¿½åŠ ã—ã¦ãã ã•ã„ã€‚ä¿¡é ¼æ€§ãŒä¹ã—ã„è¨˜è¿°ã¯ã€ç–‘å•ãŒå‘ˆã•ã‚ŒãŸã‚Šã€é™¤åŽ»ã•ã‚Œã‚‹ã“ã¨ãŒã‚ã‚Šã¾ã™ã€‚ å‡ºå…¸æ¤œç´¢?:Â "åˆ†åæ¨™çš„æ²»ç™‚"Â â€“Â ãƒ‹ãƒ¥ãƒ¼ã‚¹Â Â· æ›¸ç±Â Â· ã‚¹ã‚«ãƒ©ãƒ¼Â Â· CiNiiÂ Â· J-STAGEÂ Â· NDLÂ Â· dlib.jpÂ Â· ã‚¸ãƒ£ãƒ‘ãƒ³ã‚µãƒ¼ãƒÂ Â· TWL (2023å¹´2æœˆ) åˆ†åæ¨™çš„æ²»ç™‚ï¼ˆã¶ã‚“ã—ã²ã‚‡ã†ã¦ãã¡ã‚Šã‚‡ã†ã€è‹±: molecularly-targeted therapyï¼‰ã¨ã¯ã€ã‚ã‚‹ç‰¹å®šã®åˆ†åã‚’æ¨™çš„ã¨ã—ã¦ã€ãã®æ©Ÿèƒ½ã‚’åˆ¶å¾¡ã™ã‚‹ã“ã¨ã«ã‚ˆã‚Šæ²»ç™‚ã™ã‚‹ç™‚æ³•ã€‚ æ£å¸¸ãªä½“ã¨ç—…æ°—ã®ä½“ã®é•ã„ã‚ã‚‹ã„ã¯ç™Œç´°èƒžã¨æ£å¸¸ç´°èƒžã®é•ã„ã‚’ã‚²ãƒŽãƒ ãƒ¬ãƒ™ãƒ«ãƒ»åˆ†åãƒ¬ãƒ™ãƒ«ã§è§£æ˜Žã—ã€ãŒã‚“ã®å¢—æ®–ã‚„è»¢ç§»ã«å¿…è¦ãªåˆ†åã‚’ç‰¹ç•°çš„ã«æŠ‘ãˆãŸã‚Šé–¢ç¯€ãƒªã‚¦ãƒžãƒãªã©ã®ç‚Žç—‡æ€§ç–¾æ‚£ã§ç‚Žç—‡ã«é–¢ã‚ã‚‹åˆ†åã‚’
poccopen 2010/11/25
ãŠã‰ã‰ã€ãƒ¢ãƒŽã‚¯ãƒãƒ¼ãƒŠãƒ«æŠ—ä½“ç³»åˆ†åæ¨™çš„è–¬ã®å‘½åã£ã¦ã€ã‚ãƒ¡ãƒ©æŠ—ä½“â†’ï½žã‚ã‚·ãƒžãƒ–ã€ãƒ’ãƒˆåŒ–æŠ—ä½“â†’ï½žã‚ºãƒžãƒ–ã€ãƒ’ãƒˆæŠ—ä½“â†’ï½žãƒ ãƒžãƒ–ã€ã£ã¦ã„ã†è¦å‰‡(æ…£ç¿’ï¼Ÿ)ãŒã‚ã‚‹ã‚“ã§ã™ãã‡ã€‚

ç”Ÿç‰©

ç§‘å¦

åŒ»ç™‚

Wikipedia

æœ¬é¡Œã˜ã‚ƒãªã„ã§ã™ãŒâ†’
ãƒªãƒ³ã‚¯
ç„¡ä»‹åŠ©åˆ†å¨©ã‚’å¥½æ„çš„ã«ç´¹ä»‹ã—ãªã„ã§ãã ã•ã„ - ã¨ãƒ©ãã“æ—¥èªŒ
â– æ–°èžã«ç„¡ä»‹åŠ©åˆ†å¨©ã®äº‹ä¾‹ãŒæŽ²è¼‰ã•ã‚Œã¦ã„ãŸ åŒ»å¸«ãƒ»åŠ©ç”£å¸«é ¼ã‚‰ãšè‡ªå®…å‡ºç”£ã€€æœæ¥ã®å¤§æ£®ã•ã‚“å¤«å©¦ æœæ—¥æ–°èžã®ãƒžã‚¤ã‚¿ã‚¦ãƒ³å…µåº«ã«æŽ²è¼‰ã•ã‚ŒãŸè¨˜äº‹ã®ã‚¿ã‚¤ãƒˆãƒ«ã§ã™ã€‚è¨˜äº‹å†…å®¹ã¯æ¬¡ã®é€šã‚Šã§ã™ã€‚ æœæ¥å¸‚å’Œç”°å±±ç”ºã®å±±ã‚ã„ã«ã‚ã‚‹æœæ—¥åœ°åŒºã§ã€è¾²æ¥ã‚„é¤Šèœ‚ãªã©ã‚’å–¶ã¿ãªãŒã‚‰è‡ªçµ¦è‡ªè¶³ã®ç”Ÿæ´»ã‚’å®Ÿè·µã—ã¦ã„ã‚‹å¤§æ£®ã’ã‚“ã•ã‚“ï¼ˆï¼’ï¼™ï¼‰ã€æ¢¨ç´—åã•ã‚“ï¼ˆï¼“ï¼ï¼‰å¤«å©¦ã«ï¼‘ï¼æœˆã€ä¸‰ç”·ã‹ã‚„ã¡ã‚ƒã‚“ãŒç”Ÿã¾ã‚ŒãŸã€‚å¦Šå¨ ã®ç¢ºèªä»¥å¤–ã¯åŒ»å¸«ã«ã‚‚åŠ©ç”£å¸«ã«ã‚‚é ¼ã‚‰ãšã€å®šæœŸçš„ãªå¦Šå©¦æ¤œè¨ºã‚‚ä¸€åº¦ã‚‚å—ã‘ãªã‹ã£ãŸå®Œå…¨ãªè‡ªå®…å‡ºç”£ã€‚ï¼‘ï¼—æ—¥ã«ç”£å¾Œï¼‘ã‚«æœˆã‚’è¿Žãˆã‚‹ãŒã€æ¯åã¨ã‚‚ã«å¥åº·ã ã€‚ ã‹ã‚„ã¡ã‚ƒã‚“ã®èª•ç”Ÿã¯ï¼‘ï¼æœˆï¼‘ï¼—æ—¥åˆå¾Œï¼‘ï¼‘æ™‚ã”ã‚ã€‚åŒï¼–æ™‚ã”ã‚ã‹ã‚‰é™£ç—›ãŒå§‹ã¾ã‚Šã€æœ¬æ ¼çš„ã«ç”£ã‚€ä½“å‹¢ã‚’å–ã‚Šå§‹ã‚ã¦ï¼“æ™‚é–“ã»ã©ã§ç”Ÿã¾ã‚ŒãŸã€‚ã€Œç”£ã‚€ã®ã¯ï¼“äººã§ã‚‚ã†ã„ã„ã‚ã€ã¨æ€ã†ã»ã©ç—›ã¿ã¯ã‚ã£ãŸã‘ã‚Œã©ã€ã‚¹ãƒ ãƒ¼ã‚ºã§ã—ãŸã€ã¨æ¢¨ç´—åã•ã‚“ã€‚ é•·ç”·ã¤ãã—å›ï¼ˆï¼–ï¼‰ã‚’åŠ©ç”£é™¢ã§ã€æ¬¡ç”·ã™ãŽãªå›ï¼ˆï¼“ï¼‰ã‚’ç—…é™¢ã§ç”£ã¿ã€æ¯Žæœˆã®å¦Šå©¦æ¤œè¨ºãªã©ã§è‡ªåˆ†ã®æ€ã„ã¨ã¯
poccopen 2010/11/20
åŒ»ç™‚

ãƒ¡ãƒ‡ã‚£ã‚¢
ãƒªãƒ³ã‚¯
ã¯ã¦ãªãƒ–ãƒã‚° | ç„¡æ–™ãƒ–ãƒã‚°ã‚’ä½œæˆã—ã‚ˆã†
æ¯Žæ—¥ãƒ–ãƒã‚°ã‚’æ›¸ãã‚ˆã†ã«ã—ãŸã‚‰ä½“èª¿ãŒè‰¯ããªã£ãŸ ã‚ã‚‹æ—¥ãµã¨ã€ã€Œæœ€è¿‘ã®è‡ªåˆ†ã¯ã‚¢ã‚¦ãƒˆãƒ—ãƒƒãƒˆã«è‡†ç—…ã«ãªã£ã¦ã„ã‚‹ãªãƒ¼ã€ã¨æ„Ÿã˜ã€ã“ã†ã„ã†ã‚¨ãƒ³ãƒˆãƒªã‚’æ›¸ã„ãŸã€‚ daiksy.hatena blog.jp å†…å®¹ã¯ã€é›‘ãªã‚¢ã‚¦ãƒˆãƒ—ãƒƒãƒˆã§ã€Œã ã„ãã—ãƒ¼ã•ã‚“è€ƒãˆãŒæµ…ã„ãªã€ã¿ãŸã„ãªã€ŒåŒ–ã‘ã®çš®ãŒå‰¥ãŒã‚Œã‚‹ã€ã“ã¨ã‚’æã‚Œã¦ã„ã‚‹ãŒã€è‡ªåˆ†ãŒéŽå‰°ã«æ„è˜ã™ã‚‹ã»ã©â€¦
poccopen 2010/11/13
åŒ»ç™‚

ãƒ¡ãƒ‡ã‚£ã‚¢
ãƒªãƒ³ã‚¯
ã€æœæ—¥æ–°èž ã‚ªãƒ”ãƒ‹ã‚ªãƒ³ è‡¨åºŠè©¦é¨“ã‚’è€ƒãˆã‚‹ã€‘by rijin_nakamura +Î±
ä¸Šã€€æ˜Œåºƒ @KamiMasahiro æœæ—¥æ–°èžã®ã‚ªãƒ”ãƒ‹ã‚ªãƒ³ã€‚è‡¨åºŠç ”ç©¶ã®åˆ¶åº¦å•é¡Œã‚’è°è«–ã€‚ã¾ã‚ã€ã“ã‚Œã¯é‡è¦ã ã‘ã©ã€ã„ã¾å•ã‚ã‚Œã¦ã„ã‚‹ã®ã¯ã€ŒãƒŠãƒã‚¹ã‚’å¼•ç”¨ã—ãŸåèª‰æ¯€æã€ã¨ã€Œè¨˜äº‹æé€ ç–‘æƒ‘ã€ã€‚å…±åŒè¨˜äº‹ã¯ç›—ç”¨ã™ã‚‹ã—ã€æ‰¹åˆ¤ã•ã‚ŒãŸã‚‰é ¬è¢«ã‚Šã€‚æœæ—¥æ–°èžã®éš è”½ä½“è³ªã¯é…·ã„ãªã‚ã€‚ ä¸Šã€€æ˜Œåºƒ @KamiMasahiro æœæ—¥ãŒã‚“ãƒ¯ã‚¯ãƒãƒ³å ±é“ã€‚å½¼ã‚‰ã®ä¸»å¼µã¯ã€Œè‡¨åºŠç ”ç©¶ã®å›½å®¶ç®¡ç†ã€ã€‚åŽšåŠ´çœã«å±Šã‘å‡ºã‚‹ã ã‘ã§ã€ã‚ˆããªã£ãŸã‚Šã—ãªã„ã€‚æ¤œå¯Ÿå©ãã‚’ã—ã¦ã„ã‚‹ã‚ˆã“ã§ã€ã‚ˆãè¨€ãˆãŸãªã‚ã€‚æœæ—¥ã¯ã€è¦ã¯ã€ŒãŠä¸Šä¾å˜ã€ã€Œè¡Œæ”¿ç™’ç€ä½“è³ªã€ãªã ã‘ã ã€‚è‡ªåˆ†ã®æ‚£è€…ã‚’åŠ©ã‘ã‚‹ãŸã‚ã€æ‰‹å¼å½“ã§é›†ã¾ã£ãŸåŒ»å¸«ãŸã¡ã‚’ã€ã²ãªå£‡ã‹ã‚‰å©ããªã€‚ ä¸æ‘åˆ©ä» @rijin_nakamura åŒ—å¤§ã®è¨˜äº‹ãƒ‡ãƒ¼ã‚¿ãƒ™ãƒ¼ã‚¹ã‹ã‚‰ã€ä»–ã®æœ¬æ—¥è¨˜äº‹ã¯å…¨æ–‡èªã‚ã‚‹ãŒã€ã“ã®è¨˜äº‹ã ã‘ã¯ã€Œè‘—ä½œæ¨©ãªã©ã®é–¢ä¿‚ã€ã§ã‚¢ã‚¯ã‚»ã‚¹ä¸èƒ½ã€‚â€¦ãƒãƒƒãƒˆã§åºƒã¾ã£ã¦ã¯ä¸éƒ½åˆãªã‚“ã ã‚ã†ã€‚â€¦å£²åº—è¡Œã£ã¦ãã‚‹ã‹ã€‚ QT @KamiMasahiro æœ
poccopen 2010/11/11
åŒ»ç™‚

ãƒ¡ãƒ‡ã‚£ã‚¢

ã‚ã¨ã§èªã‚€
ãƒªãƒ³ã‚¯
ã‚¢ãƒ”ã‚¿ãƒ«ï¼ˆåŒ»ç™‚ãƒ»å¥åº·ãƒ»ä»‹è·ï¼‰ï¼šæœæ—¥æ–°èžãƒ‡ã‚¸ã‚¿ãƒ«
å‰åŽŸã•ã‚“ã®æã„ãŸãƒ—ãƒ¼ã•ã‚“ã®çµµã€‚ãƒ—â€¦ ãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ»ãƒ•ã‚©ãƒ¼ã‚«ã‚¹ã€Œæ²»ã›ã‚‹èªçŸ¥ç—‡ã€ã®æ‰‹è¡“ã€€è² æ‹…å°‘ãªã„æ‰‹æ³•ã€ã˜ã‚ã‚ŠåºƒãŒã‚‹(2019/8/14)ï»¿ ã€Œæ²»ã›ã‚‹èªçŸ¥ç—‡ã€ã¨å‘¼ã°ã‚Œã‚‹ã€Œç‰¹ç™ºæ€§æ£å¸¸åœ§æ°´é ç—‡ã€ã¨ã„ã†ç—…æ°—ãŒã‚ã‚‹ã€‚è¿‘å¹´ã¯æ‚£è€…ã®å¿ƒç†çš„ãªè² æ‹…ãªã©ãŒå°‘ãªã„æ‰‹è¡“ãŒæ³¨ç›®ã‚’é›†ã‚ã¦ã„ã‚‹ã€‚ã„ã£ãŸã„ã©â€¦[ç¶šãã‚’èªã‚€] æ‰‹è¡“åŠ¹æžœã‚„èªçŸ¥ç—‡ã®åˆä½µã®è©•ä¾¡â€¦ã€Œæ²»ã›ã‚‹èªçŸ¥ç—‡ã€ã®èª²é¡Œ[ãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ»ãƒ•ã‚©ãƒ¼ã‚«ã‚¹](2019/8/14) è€³é³´ã‚Šã€è¦‹ãˆãªã„ã¤ã‚‰ã•ã€€ã€Œç”Ÿãã‚‹é™ã‚Šä»˜ãåˆã†ã€ã¨è¦šæ‚Ÿ[æ‚£è€…ã‚’ç”Ÿãã‚‹](2019/8/14) ï»¿ ãã®ç—›ã¿ã€æœ¬å½“ã«äº”åè‚©ï¼Ÿã€€ã€ŒèƒŒæ³³ãŽãƒ†ã‚¹ãƒˆã€ã§ç¢ºèªã‚’[ãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ»ãƒ•ã‚©ãƒ¼ã‚«ã‚¹](2019/8/12) ï»¿ æŠ—ãŒã‚“å‰¤ã®è„±æ¯›æŠ‘ãˆã‚‹æ©Ÿå™¨ã€ä¿é™ºé©ç”¨ãªãã€€åˆ©ç”¨ã¯è‡ªè²»ã§[ãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ»ãƒ•ã‚©ãƒ¼ã‚«ã‚¹](2019/8/13) ï»¿ æ—§æ—¥æœ¬çµ±æ²»ä¸‹ã®ãƒãƒ³ã‚»ãƒ³ç—…ã€Œç›£ç¦å®¤ã€ç´¹ä»‹ã€€ç¾¤é¦¬ã§ä¼ç”»å±•[ãƒ‹ãƒ¥ãƒ¼ã‚¹ãƒ»ãƒ•ã‚©ãƒ¼ã‚«ã‚¹](2019/8/15) ã‚¨ãƒœãƒ©å‡ºè¡€
poccopen 2010/11/11
åŒ»ç™‚

ã‚ã¨ã§èªã‚€
ãƒªãƒ³ã‚¯
Vol. 346 å¤§ä¸ˆå¤«ã‹æœæ—¥æ–°èžã®å ±é“å§¿å‹¢ã€€II - MRIC by åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼š
åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼š (2010å¹´11æœˆ10æ—¥ 20:00) | ã‚³ãƒ¡ãƒ³ãƒˆ(0) | ãƒˆãƒ©ãƒƒã‚¯ãƒãƒƒã‚¯(0) æ±äº¬å¤§å¦åŒ»ç§‘å¦ç ”ç©¶æ‰€ã€€æ‰€é•·ã€€æ¸…æœ¨å…ƒæ²» 2010å¹´11æœˆ10æ—¥ã€€ï¼ï¼²ï¼©ï¼£ by åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼šã€€ç™ºè¡Œã€€ã€€http://medg.jp 10æœˆ15æ—¥ã‹ã‚‰å§‹ã¾ã£ãŸä¸€é€£ã®æœæ—¥æ–°èžå ±é“ã®å•é¡Œç‚¹ã¯ã€11æœˆ10æ—¥ä»˜ã®ã€Œã‚ªãƒ”ãƒ‹ã‚ªãƒ³ã€è¨˜äº‹ã¾ã§ã€ãã®ç—…æ ¹ã‚’å¼•ããšã£ã¦ã„ã‚‹ã‚ˆã†ã§ã™ã€‚ç‰¹ã«è±¡å¾´çš„ã§åˆ¤ ã‚Šã‚„ã™ã„ä¾‹ã¯ã€10æœˆ20æ—¥ã«ç™ºè¡¨ã•ã‚ŒãŸãŒã‚“æ‚£è€…ï¼”ï¼‘å›£ä½“ã®å£°æ˜Žã‚’ä¼ãˆã‚‹æœæ—¥æ–°èžã®è¨˜äº‹ã§ã™ã€‚å£°æ˜Žã«ã¯ã€ã€Œè‡¨åºŠè©¦é¨“ã«ãŠã‘ã‚‹æœ‰å®³äº‹è±¡ç‰ã®å ±é“ã«ã¯ã€ãŒã‚“æ‚£ è€…ã‚’å«ã‚€ä¸€èˆ¬å›½æ°‘ã®è¦–ç‚¹ã‚’è€ƒãˆã€èª¤è§£ã‚’ä¸Žãˆã‚‹ã‚ˆã†ãªä¸é©åˆ‡ãªå ±é“ã§ã¯ãªãã€äº‹å®Ÿã‚’åˆ¤ã‚Šæ˜“ãä¼ãˆã‚‹ã‚ˆã†ã€å†·é™ãªå ±é“ã‚’æ±‚ã‚ã¾ã™ã€ã¨ã‚ã‚Šã¾ã—ãŸã€‚15æ—¥ä»˜ã®è¨˜ äº‹ã‚’è¦‹ã¦å¤§å¤‰å‹•æºã—ãŸæ‚£è€…ã®æ°—æŒã¡ã‚’ä»£è¡¨ã™ã‚‹å½¢ã§ã€å ±é“ã¸ã®è¦æœ›ãŒå¼·ãè¡¨ã‚ŒãŸå†…å®¹ã§ã™ã€‚ã—ã‹ã—ã€ç¿Œ10æœˆ21æ—¥ï¼ˆæœåˆŠ38é¢ï¼‰ã®
poccopen 2010/11/11
åŒ»ç™‚

ãƒ¡ãƒ‡ã‚£ã‚¢
ãƒªãƒ³ã‚¯
Vol. 338 "è‡ªç„¶ãªãŠç”£"ãƒ–ãƒ¼ãƒ ã«è¦é˜ã‚’ã€‚åŠ©ç”£é™¢ãƒ»è‡ªå®…åˆ†å¨©ã®å•é¡Œç‚¹ã‚’åºƒãè€ƒãˆã¦æ¬²ã—ã„ - MRIC by åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼š
Vol. 338 "è‡ªç„¶ãªãŠç”£"ãƒ–ãƒ¼ãƒ ã«è¦é˜ã‚’ã€‚åŠ©ç”£é™¢ãƒ»è‡ªå®…åˆ†å¨©ã®å•é¡Œç‚¹ã‚’åºƒãè€ƒãˆã¦æ¬²ã—ã„ åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼š (2010å¹´11æœˆ 4æ—¥ 06:00) | ã‚³ãƒ¡ãƒ³ãƒˆ(0) | ãƒˆãƒ©ãƒƒã‚¯ãƒãƒƒã‚¯(0) æ˜Ÿé‡Žè²´å ãƒ–ãƒã‚°ã€ŒåŠ©ç”£é™¢ã¯å®‰å…¨ï¼Ÿã€ç®¡ç†è€… 2010å¹´11æœˆ4æ—¥ã€€ï¼ï¼²ï¼©ï¼£ by åŒ»ç™‚ã‚¬ãƒãƒŠãƒ³ã‚¹å¦ä¼šã€€ç™ºè¡Œã€€ã€€http://medg.jp ã€ç§ãŒ"è‡ªç„¶ãªãŠç”£"ã§å¤±ã£ãŸã‚‚ã®ã€‘ ç§ã¯2003å¹´ã®8æœˆã«ç¬¬ä¸€åã‚’æ ƒæœ¨çœŒå†…ã®åŠ©ç”£æ‰€ã§åˆ†å¨©ã—ã¾ã—ãŸã€‚å¦Šå¨ ä¸ã‹ã‚‰é€†åã ã¨çŸ¥ã‚Šã€é‡Œå¸°ã‚Šå‡ºç”£ã§äºˆç´„ã—ã¦ã„ãŸåŠ©ç”£é™¢ã§ã¯ã€Œé€†åãªã‚‰ç—…é™¢ã€ã¨è¨€ã‚ ã‚ŒãŸã®ã§ã€çŸ¥äººã‹ã‚‰"é€†åç›´ã—ã®åäºº"ã¨ã—ã¦æœ‰åã ã¨ã„ã†ï¼¨åŠ©ç”£å¸«ã‚’ç´¹ä»‹ã•ã‚Œã¾ã—ãŸã€‚ãã®åŠ©ç”£å¸«ã‚ˆã‚Šã€Œé€†åã®æ–¹ãŒç°¡å˜ã ï¼ˆç‰¹ã«è¶³ã‹ã‚‰ã ã¨ç°¡å˜ã ã¨ã„ã†ã‚ˆã† ãªèª¬æ˜Žã§ã—ãŸï¼‰ã€ã€Œç—…é™¢ã§å¸çŽ‹åˆ‡é–‹ã—ãŸäººãŒéº»é…”ã®é‡ã‚’é–“é•ã‚ã‚Œã¦ã—ã¾ã„ã€åä¾›ãŒæ»ã‚“ã äººãŒæ¬¡ã®å¦Šå¨ ã§æ¥ãŸã€ç‰ã¨è©±ã‚’èžãã€ã“ã®åŠ©ç”£é™¢ã§ãŠç”£ã‚’
poccopen 2010/11/06
åŒ»ç™‚
ãƒªãƒ³ã‚¯
1 2 3 æ¬¡ã®ãƒšãƒ¼ã‚¸